Disclaimers

Disclaimers

IMPORTANT: This protocol generation tool provides preliminary clinical study protocol based on NIH/FDA guidelines and similar trials. It does NOT constitute:

• Official FDA or IRB determination or approval
• Medical, legal, or regulatory advice
• Substitute for professional biostatistician review
• Substitute for FDA Pre-Submission meeting
• Guarantee of regulatory or clinical success

REQUIRED before proceeding with clinical study:

• Biostatistician review and sample size validation
• FDA Pre-Submission meeting (Q-Submission for devices, Pre-IND for drugs)
• IRB review and approval
• Clinical expert and regulatory consultant engagement
• Legal review of protocol and informed consent
• Site investigator review and input
• Sponsor completion of all [TBD] items in protocol

PROFESSIONAL CONSULTATION STRONGLY RECOMMENDED

Clinical trial protocols are complex, high-stakes documents requiring expertise across multiple disciplines. Professional consultation with clinical trial experts, biostatisticians, and regulatory affairs specialists is essential before proceeding with clinical study planning.